More articles from Commentary

You have access
Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology
F. L. Wood, J. B. Houston and D. Hallifax

Drug Metabolism and Disposition November 2017, 45 (11) 1178-1188; DOI: https://doi.org/10.1124/dmd.117.077040
You have access
When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?
Stephan T. Stern, Marilyn N. Martinez and David M. Stevens

Drug Metabolism and Disposition December 2016, 44 (12) 1934-1939; DOI: https://doi.org/10.1124/dmd.116.073148
You have access
Absorption Differences between Immediate-Release Dexmethylphenidate and dl-Methylphenidate
Kennerly S. Patrick and Arthur B. Straughn

Drug Metabolism and Disposition March 2016, 44 (3) 418-421; DOI: https://doi.org/10.1124/dmd.115.067975
You have access
A Perspective on the Contribution of Metabolites to Drug-Drug Interaction Potential: The Need to Consider Both Circulating Levels and Inhibition Potency
Hongbin Yu and Donald Tweedie

Drug Metabolism and Disposition March 2013, 41 (3) 536-540; DOI: https://doi.org/10.1124/dmd.112.048892
You have access
Commentary: Theoretical Predictions of Flow Effects on Intestinal and Systemic Availability in Physiologically Based Pharmacokinetic Intestine Models: The Traditional Model, Segregated Flow Model, and Q_Gut Model
K. Sandy Pang and Edwin C. Y. Chow

Drug Metabolism and Disposition October 2012, 40 (10) 1869-1877; DOI: https://doi.org/10.1124/dmd.112.045872
You have access
Commentary: Nonspecific Protein Binding versus Membrane Partitioning: It Is Not Just Semantics
Swati Nagar and Ken Korzekwa

Drug Metabolism and Disposition September 2012, 40 (9) 1649-1652; DOI: https://doi.org/10.1124/dmd.112.046599
You have access
IMPACT OF CYP2C9 GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?
A. David Rodrigues

Drug Metabolism and Disposition November 2005, 33 (11) 1567-1575; DOI: https://doi.org/10.1124/dmd.105.006452
You have access
SEEING THROUGH THE MIST: ABUNDANCE VERSUS PERCENTAGE. COMMENTARY ON METABOLITES IN SAFETY TESTING
Dennis A. Smith and R. Scott Obach

Drug Metabolism and Disposition October 2005, 33 (10) 1409-1417; DOI: https://doi.org/10.1124/dmd.105.005041
You have access
Commentary: David Kupfer, Ph.D., 1925–2004
John Schenkman

Drug Metabolism and Disposition April 2005, 33 (4) 483; DOI: https://doi.org/10.1124/dmd.105.003582
You have access
THE ROLES OF TRANSPORTERS AND ENZYMES IN HEPATIC DRUG PROCESSING
Lichuan Liu and K. Sandy Pang

Drug Metabolism and Disposition January 2005, 33 (1) 1-9; DOI: https://doi.org/10.1124/dmd.104.001149

Main menu

User menu

Search

More articles from Commentary

Pages

Navigate

More Information

ASPET's Other Journals